Inventor
EVANS CATHERINE A
US40 patents
⚠️ This page may combine multiple inventors who share the name “EVANS CATHERINE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFINITY PHARMACEUTICALS INC
26 patentsUS9181221B2Nov 10, 2015
Chemical compounds, compositions and methods for kinase modulation
INFINITY PHARMACEUTICALS INC64 citations98
US9359365B2Jun 7, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC24 citations94
US8940742B2Jan 27, 2015
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC35 citations94
US9388183B2Jul 12, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC19 citations93
US9255108B2Feb 9, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC21 citations93
US9115141B2Aug 25, 2015
Substituted isoquinolinones and methods of treatment thereof
INFINITY PHARMACEUTICALS INC27 citations93
US9775844B2Oct 3, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC13 citations92
US10329299B2Jun 25, 2019
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC7 citations84
US9828377B2Nov 28, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC4 citations84
US9708348B2Jul 18, 2017
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
INFINITY PHARMACEUTICALS INC13 citations84
US8349814B2Jan 8, 2013
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations74
US7947663B2May 24, 2011
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC6 citations74
US11541059B2Jan 3, 2023
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC2 citations73
US10759806B2Sep 1, 2020
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
INFINITY PHARMACEUTICALS INC3 citations73
US9751888B2Sep 5, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC2 citations73
US9605003B2Mar 28, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC3 citations73
US9546180B2Jan 17, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC2 citations73
US9108989B2Aug 18, 2015
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC1 citations63
US8629125B2Jan 14, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations63
US12152032B2Nov 26, 2024
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations62
US10941162B2Mar 9, 2021
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations62
US10919914B2Feb 16, 2021
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations52
US10253047B2Apr 9, 2019
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations52
US9738644B2Aug 22, 2017
Chemical compounds, compositions and methods for kinase modulation
INFINITY PHARMACEUTICALS INC0 citations52
US9718815B2Aug 1, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations52
US8802119B2Aug 12, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC0 citations52
CASTRO ALFREDO C
4 patentsUS8785470B2Jul 22, 2014
Heterocyclic compounds and uses thereof
CASTRO ALFREDO C41 citations98
US8969363B2Mar 3, 2015
Heterocyclic compounds and uses thereof
CASTRO ALFREDO C44 citations94
US9056877B2Jun 16, 2015
Heterocyclic compounds and uses thereof
CASTRO ALFREDO C25 citations92
US8541581B2Sep 24, 2013
Inhibitors of fatty acid amide hydrolase
CASTRO ALFREDO C3 citations63
BEHNKE MARK L
4 patentsUS9149465B2Oct 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations49
US8765735B2Jul 1, 2014
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L1 citations49
US8957049B2Feb 17, 2015
Inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39
US8927551B2Jan 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39